• A&D Company, Limited has entered into a US$1M investment agreement with Aevice Health
• The collaboration is geared towards jointly expanding Aevice Health's presence in both the Japanese and US markets
• The collaboration will also give Aevice Health access to A&D Company, Limited's expertise in medical technology development and sales network. A&D Company, Limited will leverage Aevice Health's technology to create novel healthcare solutions
• This collaboration is fostered by the Japan External Trade Organisation (JETRO)Singapore

‍

Singapore, 15 May 2024 — Aevice Health, a leading provider of remote respiratory monitoring solutions, today announced that it has secured a US$1 million investment fromA&D Company, Limited. This investment marks a significant milestone for Aevice Health as it extends its US FDA-cleared and Singapore HSA-approved flagship product, the AeviceMD, into the Japanese and US markets.

Headquartered in Tokyo, Japan, A&D Company, Limited is a world leader in the design and manufacturing of precision measurement and product inspection equipment for healthcare, laboratories, and various industrial markets, operating in 13 countries. Its whollyowned US subsidiary, A&D Engineering, Inc., specializes in the manufacturing and distribution of connected health and advanced biometric monitoring solutions for consumer and professional use.

Under this agreement, A&D Company, Limited will acquire equity in Aevice Health, and secure rights to invest in subsequent rounds. This collaboration enables Aevice Health to tap into A&D Company, Limited's expertise in medical technology and extensive sales network.In turn, A&D Company, Limited can leverage Aevice Health's innovative digital health technology to develop innovative products and services addressing today’s healthcare challenges and enhancing value for healthcare professionals and patients alike.

“It is a privilege to work with A&D Company, Limited and its subsidiaries to enhance the clinical application of our solutions to tackle a variety of diseases. With their invaluable technical and commercialization expertise, we are excited to work together to realize our vision of enhancing care for patients with respiratory diseases. Additionally, we would like to thank JETRO Singapore for facilitating this collaboration between A&D Company, Limited and Aevice Health”, said Adrian Ang, CEO and Co-Founder of Aevice Health.

“We are delighted to announce our investment in Aevice Health. This collaborationwill strengthen our ability to develop solutions for the health challenges facing society. We are eager to leverage our expertise and technology together to further our joint mission of improving patient care for those with respiratory conditions”, said Yasunobu Morishima, Representative Director and President of A&D Company, Limited.

The collaboration between A&D Company, Limited, and Aevice Health was made possible through the efforts of JETRO Singapore, which played a crucial role in connecting and facilitating cooperation between the 2 companies.

‍

Background Information

Chronic respiratory diseases, the third leading cause of global mortality, claimed over 4 million lives in 2019. In the US and Japan, these diseases impose a heavy economic burden, with healthcare spending totaling US$170.8 billion (2016) and ¥1.5 trillion (2019) respectively. This burden is particularly pronounced among the elderly population, who often require frequent monitoring and face barriers to access due to the uneven distribution of physicians between urban and rural areas.

AeviceMD is a Singapore HSA-approved and US FDA-cleared patient management platform for chronic respiratory disease management, featuring a smart wearable stethoscope suitable for all ages. The platform continuously monitors for biomarkers of interest such as wheezing and early signs of exacerbation. By providing healthcare professionals with patients’ longitudinal data and the capability to utilize a remote stethoscope on their patients, the AeviceMD enables comprehensive lung health assessments to be conveniently conducted from the patient’s homes.

About Aevice Health
Aevice Health is a digital health company dedicated to improving asthma and COPD care through its proprietary, non-invasive remote patient monitoring platform and wearable stethoscope, the AeviceMD. Its cutting-edge technology allows for continuous monitoring and real-time disease deterioration tracking, enabling patients to receive personalized care from the comfort of their homes. With actionable insights and effortless treatment response monitoring, healthcare professionals can make timely adjustments for optimized patient outcomes. Aevice Health is on a mission to improve healthcare accessibility, empower patients, and reduce healthcare costs.

More information about the company can be found at www.aevice.com.

‍

About A&D Company, Limited

‍A&D Company, Limited is a research and development-oriented company, with nearly half of our workforce engaged in product design and development. We are committed to creating products that maintain the highest standards of quality, precision, and user-friendliness. Our medical and healthcare business provides equipment supporting the health and well-being of people worldwide.

More information about the company can be found at https://www.aandd.jp/.

‍

For media enquiries, please contact:
‍Janelle Low
Business Development Manager
Aevice Health Pte Ltd
Email: janellelow@aevice.com

Tomoyuki Ishikawa
Corporate Strategic Planning Division
A&D Company, Limited
Phone:＋81-48-593-1114